Chinese group pays $239m for Australian vitamin firm
Shanghai Pharmaceuticals Holding Co Ltd and private equity firm Primavera Capital is to buy Australian vitamin manufacturer Vitaco Holdings for US$239m.
News, Analysis & Insights on Nutrition, Supplements, and Health
- Home
- Allergies & intolerances
- Beauty from within
- Blood sugar management
- Bone & joint health
- Cancer risk reduction
- Cardiovascular health
- Cognitive function
- Energy
- Eye health
- Gut/digestive health
- Healthy ageing
- Immune support
- Inflammation
- Maternal & infant health
- Men's Health
- Oral/gum health
- Respiratory health
- Skin health
- Sports nutrition
- Weight management
- Women's health
- Antioxidants/carotenoids
- Botanicals
- Dairy-based ingredients
- Dosage forms & delivery formats
- Fibres & carbohydrates
- Minerals
- Nutricosmetics
- Omega-3s & nutritional oils
- Polyphenols
- Probiotics, prebiotics & postbiotics
- Proteins, peptides, amino acids
- Soya-based ingredients
- Vitamins & premixes
- Partners
- Scientific Frontiers
- China 中国
- Japan 日本